Between 30% and 50% of people living with multiple sclerosis (MS) will experience memory problems, but the cause is uncertain. Brain lesions are the hallmark imaging sign used to diagnose MS and are ...

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of ...

Between 30 to 50 percent of people living with multiple sclerosis (MS) will experience memory problems but the cause is uncertain. Brain lesions are the hallmark imaging sign used to diagnose MS and ...

Roche RHHBY announced new data from the mid-stage study on an experimental candidate, fenebrutinib, for treating relapsing multiple sclerosis (“RMS”). Fenebrutinib is an investigational oral, ...

Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led ...

In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, may not be the ...

Christina Applegate opened up about the symptoms she’s experienced throughout her battle with Multiple Sclerosis (MS) during a recent podcast interview on Monday, March 25. The sitcom star, 52, was ...

The combination of cortical lesions and central vein sign in MRI increases the specificity and sensitivity for diagnosing multiple sclerosis. This study suggests that CLs and CVS, when used together, ...

Christina Applegate is revealing more about her health challenges. The "Dead to Me" star, 52, opened up about her battle with multiple sclerosis on Monday's episode of Dax Shepard's "Armchair Expert" ...